Skip to main navigation Skip to search Skip to main content

Blinatumomab vs Chemotherapy among Children with Relapsed Acute Lymphoblastic Leukemia - Reply

  • Amgen Incorporated
  • Charité – Universitätsmedizin Berlin

Research output: Contribution to journalArticle

Abstract

NO ABSTRACT
Original languageEnglish
Pages (from-to)359-360
Number of pages2
JournalJAMA
Volume326
Issue number4
DOIs
Publication statusPublished - 2021

All Science Journal Classification (ASJC) codes

  • General Medicine

Keywords

  • BLINATUMOMAB

Fingerprint

Dive into the research topics of 'Blinatumomab vs Chemotherapy among Children with Relapsed Acute Lymphoblastic Leukemia - Reply'. Together they form a unique fingerprint.

Cite this